Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Hanssen

Showing results (91-100 of 118) with videos related to

Pageof 12
Sort By:
The Lancet. Diabetes & Endocrinology|July 19, 2025
Sex-based disparities in perceived versus objective glycaemic control in type 1 diabetes: a cross-sectional cohort studyCoco M Fuhri Snethlage, Paul Smeets, Pleun de Groen, et al.
Gut Microbes|October 6, 2025
Autologous fecal microbiota capsules are safe and potentially preserve beta-cell function in individuals with type 1 diabetesPleun de Groen, Coco M Fuhri Snethlage, Koen Wortelboer, et al.
Diabetologia|June 26, 2024
Associations between diabetes-related genetic risk scores and residual beta cell function in type 1 diabetes: the GUTDM1 studyCoco M Fuhri Snethlage, Manon Balvers, Bart Ferwerda, et al.
Diabetes|May 23, 2014
Plasma advanced glycation end products are associated with incident cardiovascular events in individuals with type 2 diabetes: a case-cohort study with a median follow-up of 10 years (EPIC-NL)Nordin M J Hanssen, Joline W J Beulens, Susan van Dieren, et al.
Diabetologia|August 15, 2023
Atorvastatin lowers <sup>68</sup>Ga-DOTATATE uptake in coronary arteries, bone marrow and spleen in individuals with type 2 diabetesReindert F Oostveen, Yannick Kaiser, Mia R Ståhle, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 13, 2026
Practice variation, outcomes and definitions of suppressive antimicrobial therapy for prosthetic joint infections: a systematic review and expert consensus statementJaap L J Hanssen, Bart Pijls, Marjan Wouthuyzen-Bakker, et al.
The Journal of Clinical Endocrinology and Metabolism|June 20, 2013
Plasma levels of advanced glycation endproducts Nε-(carboxymethyl)lysine, Nε-(carboxyethyl)lysine, and pentosidine are not independently associated with cardiovascular disease in individuals with or without type 2 diabetes: the Hoorn and CODAM studiesNordin M J Hanssen, Lian Engelen, Isabel Ferreira, et al.
Diabetes, Obesity & Metabolism|July 14, 2025
Persisting plasma proinsulin levels in a cohort of 482 individuals with long-standing type 1 diabetes mellitusDouwe Frank de Wit, Coco Marjolein Fuhri Snethlage, Rana Minab, et al.
Diabetes, Obesity & Metabolism|July 29, 2025
Higher plasma dicarbonyl levels are associated with liver fibrosis in obese individualsOluwatomisono I Akinrimisi, Mijra Koning, Jean L J M Scheijen, et al.
European Journal of Endocrinology|April 29, 2024
Prevalence and predictive features of metabolic dysfunction-associated steatotic liver disease in type 1 diabetesCoco M Fuhri Snethlage, Abraham S Meijnikman, Anne Linde Mak, et al.
Pageof 12

Showing results (91-100 of 118) with videos related to

Sort By:
Pageof 12
The Lancet. Diabetes & Endocrinology|July 19, 2025
Sex-based disparities in perceived versus objective glycaemic control in type 1 diabetes: a cross-sectional cohort studyCoco M Fuhri Snethlage, Paul Smeets, Pleun de Groen, et al.
Gut Microbes|October 6, 2025
Autologous fecal microbiota capsules are safe and potentially preserve beta-cell function in individuals with type 1 diabetesPleun de Groen, Coco M Fuhri Snethlage, Koen Wortelboer, et al.
Diabetologia|June 26, 2024
Associations between diabetes-related genetic risk scores and residual beta cell function in type 1 diabetes: the GUTDM1 studyCoco M Fuhri Snethlage, Manon Balvers, Bart Ferwerda, et al.
Diabetes|May 23, 2014
Plasma advanced glycation end products are associated with incident cardiovascular events in individuals with type 2 diabetes: a case-cohort study with a median follow-up of 10 years (EPIC-NL)Nordin M J Hanssen, Joline W J Beulens, Susan van Dieren, et al.
Diabetologia|August 15, 2023
Atorvastatin lowers <sup>68</sup>Ga-DOTATATE uptake in coronary arteries, bone marrow and spleen in individuals with type 2 diabetesReindert F Oostveen, Yannick Kaiser, Mia R Ståhle, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 13, 2026
Practice variation, outcomes and definitions of suppressive antimicrobial therapy for prosthetic joint infections: a systematic review and expert consensus statementJaap L J Hanssen, Bart Pijls, Marjan Wouthuyzen-Bakker, et al.
The Journal of Clinical Endocrinology and Metabolism|June 20, 2013
Plasma levels of advanced glycation endproducts Nε-(carboxymethyl)lysine, Nε-(carboxyethyl)lysine, and pentosidine are not independently associated with cardiovascular disease in individuals with or without type 2 diabetes: the Hoorn and CODAM studiesNordin M J Hanssen, Lian Engelen, Isabel Ferreira, et al.
Diabetes, Obesity & Metabolism|July 14, 2025
Persisting plasma proinsulin levels in a cohort of 482 individuals with long-standing type 1 diabetes mellitusDouwe Frank de Wit, Coco Marjolein Fuhri Snethlage, Rana Minab, et al.
Diabetes, Obesity & Metabolism|July 29, 2025
Higher plasma dicarbonyl levels are associated with liver fibrosis in obese individualsOluwatomisono I Akinrimisi, Mijra Koning, Jean L J M Scheijen, et al.
European Journal of Endocrinology|April 29, 2024
Prevalence and predictive features of metabolic dysfunction-associated steatotic liver disease in type 1 diabetesCoco M Fuhri Snethlage, Abraham S Meijnikman, Anne Linde Mak, et al.
Pageof 12